FLT3 and acute myeloid leukemia: The depletion of this circRNA significantly impairs tumorigenicity of FLT3-ITD AML cells, highlighting this circRNA as putative relevant therapeutic target in this AML subtype (Sun et al., 2019; Figure 3C).